-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Blueprint Medicines Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2014 to 2024.
- Blueprint Medicines Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 62.9M shares, a 3.8% increase year-over-year.
- Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 62.9M shares, a 3.8% increase from 2023.
- Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 60.6M shares, a 1.54% increase from 2022.
- Blueprint Medicines Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 59.6M shares, a 1.92% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)